Table 3 Survival of the patients (months) according to gender and smoking in subgroups
RA-ILD (n = 59) | RA-UIP (n = 35, 59.3 %) | RA-non-UIP (n = 24, 40.7 %) | P-value (UIP vs. non-UIP) | |
|---|---|---|---|---|
Overall | 107.0 (73.1–140.9) | 92.0 (62.8–121.2) | 137.0 (31.0–243.0) | 0.417 |
Gender | ||||
Male | 87.0 (46.0–128.0) | 88.0 (31.0–145.0) | 87.0 (33.0–141.0) | 0.976 |
Female | 152.0 (87.7–216.3) | 92.0 (0.0–185.2) | a | 0.123 |
(p = 0.305) | (p = 0.777) | (p = 0.093) | ||
Smoking | ||||
Non-smokers | 152.0 (94.3–209.7) | 92.0 (0.0–205.4) | a | 0.174 |
Ever-smokers | 88.0 (29.4–146.6) | 88.0 (30.0–146.0) | 137.0 (43.6–230.4) | 0.754 |
(p = 0.525) | (p = 0.921) | (p = 0.218) |